Immunomedics Inc (IMMU) – Strategy, SWOT and Corporate Finance Report
- Pages: 52
- Published: September 2020
- Report Code: MLPH58576FSA
Immunomedics Inc (IMMU) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Immunomedics Inc (Immunomedics) is a biopharmaceutical company that discovers, develops, manufactures and commercializes monoclonal antibody drug conjugates for the treatment of cancer and autoimmune disorders. It offers Trodelvy, which is indicated for the treatment of metastatic triple-negative breast cancer (mTNBC) in adult patients who were previously treated with at least two therapies for metastatic disease. The company is investigating its lead product candidate, Sacituzumab govitecan (IMMU-132) for the treatment of patients with mTNBC, metastatic urothelial cancer, hormone receptor-positive (HR+) or human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC), and others. Immunomedics is advancing IMMU-130 (labetuzumab govitecan) for colorectal cancer and IMMU-140 for hematologic cancers. It develops candidates based on its proprietary technologies namely, ADC Linker technology. Immunomedics is headquartered in Morris Plains, New Jersey, the US.
Scope
• Detailed information on Immunomedics Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Immunomedics Inc in the form of a SWOT analysis
• An in-depth view of the business model of Immunomedics Inc including a breakdown and examination of key business segments
• News about Immunomedics Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Immunomedics Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Immunomedics Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Immunomedics Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
GlaxoSmithKline Plc
Celgene Corp
Biogen Inc
Amgen Inc
Seattle Genetics Inc
Johnson & Johnson
Merck Serono SA
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.